Cr. Hunt et al., C-ERBB-3 PROTOONCOGENE EXPRESSION IN UTERINE CERVICAL-CARCINOMA, International journal of gynecological cancer, 5(4), 1995, pp. 282-285
Over-expression of epidermal growth factor receptor (EGFR) and c-erbB-
2, in uterine cervical carcinomas, is associated with a worsened progn
osis. A third member of this proto-oncogene family, c-erbB-3, has now
been identified and its over-expression has been described in a variet
y of carcinomas. In this immunohistochemical study we have shown that
c-erbB-3 is widely expressed in cervical carcinomas, but we have found
no association between its over-expression and lymph node status or c
linical outcome. In a similar study examining the expression of EGFR a
nd c-erbB-2 it was possible to demonstrate an association between over
-expression and a worse prognosis. We conclude, therefore, that it is
unlikely that demonstration of c-erbB-3 over-expression will be of any
value as a prognostic indicator in carcinoma of the uterine cervix.